Literature DB >> 11146549

Ductal growth is impeded in mammary glands of C-neu transgenic mice.

S Mukherjee1, S G Louie, M Campbell, L Esserman, G Shyamala.   

Abstract

The steroid hormone, estradiol, is essential for both the growth of normal breast and induction of mammary carcinomas. The growth promoting effects of estrogen are presumed to be mediated by growth factors, in particular, epidermal growth factor, which mediates its effects through erbB receptors, erbB1 and erbB2/C-neu. C-neu is amplified and over-expressed in a large number of human cancers and transgenic mice over-expressing C-neu also develop mammary tumors. However, as yet, the impact of C-neu over-expression on estrogen action during normal mammary development and hence, its precise role in carcinogenesis, remains unclear. In the present studies, we demonstrate that estradiol-dependent mammary ductal growth accompanying puberty is impaired in transgenic mice expressing wild type Cneu, and is intrinsic to the tissue. The impairment is not due to an overall impairment in estrogen action, since progesterone receptor expression is unaffected in C-neu mice. It is also not due to an intrinsic inability of the epithelial cells to proliferate, since impeded ductal growth co-exists with alveolar growth during pregnancy. Therefore, we propose that, depending on the physiological state, C-neu may either promote or inhibit the growth of mammary epithelial cells, and discuss its potential significance to carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11146549     DOI: 10.1038/sj.onc.1203964

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo.

Authors:  Wen Bu; Yi Li
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-09       Impact factor: 2.673

2.  Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.

Authors:  Michael J Toneff; Zhijun Du; Jie Dong; Jian Huang; Parisa Sinai; James Forman; Susan Hilsenbeck; Rachel Schiff; Shixia Huang; Yi Li
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

3.  Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.

Authors:  Shom Goel; Qi Wang; April C Watt; Sara M Tolaney; Deborah A Dillon; Wei Li; Susanne Ramm; Adam C Palmer; Haluk Yuzugullu; Vinay Varadan; David Tuck; Lyndsay N Harris; Kwok-Kin Wong; X Shirley Liu; Piotr Sicinski; Eric P Winer; Ian E Krop; Jean J Zhao
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

4.  Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.

Authors:  Hexin Chen; Ji Shin Lee; Xiaohui Liang; Huiping Zhang; Tao Zhu; Zhe Zhang; M Evangeline Taylor; Cynthia Zahnow; Lionel Feigenbaum; Alan Rein; Saraswati Sukumar
Journal:  Cancer Res       Date:  2008-05-07       Impact factor: 12.701

Review 5.  The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.

Authors:  Robert A Jones; Roger A Moorehead
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-11       Impact factor: 2.673

6.  A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.

Authors:  S Castillo-Lluva; L Hontecillas-Prieto; A Blanco-Gómez; M Del Mar Sáez-Freire; B García-Cenador; J García-Criado; M Pérez-Andrés; A Orfao; M Cañamero; J H Mao; T Gridley; A Castellanos-Martín; J Pérez-Losada
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

7.  Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.

Authors:  J P Robichaux; R M Hallett; J W Fuseler; J A Hassell; A F Ramsdell
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

8.  Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.

Authors:  Balasunder R Dodda; Corry D Bondi; Mahmud Hasan; William P Clafshenkel; Katie M Gallagher; Mary P Kotlarczyk; Shalini Sethi; Ethan Buszko; Jean J Latimer; J Mark Cline; Paula A Witt-Enderby; Vicki L Davis
Journal:  Front Oncol       Date:  2019-07-09       Impact factor: 6.244

Review 9.  Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes.

Authors:  Jimmie E Fata; Zena Werb; Mina J Bissell
Journal:  Breast Cancer Res       Date:  2003-08-19       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.